Consolidated figures · ₹ crore
| ₹ Cr | Mar 2026 |
|---|---|
| Revenue | 2,124 |
| COGS | 812 |
| Gross profit | 1,312 |
| 478 | |
| 834 | |
| OPM % | 39.3% |
| Depreciation | 134 |
| Interest | 7 |
| 131 | |
| Profit before tax | 824 |
| Tax | 232 |
| Tax % | 28.2% |
| PAT | 592 |
| PAT margin % | 27.9% |
| EPS (₹) | 10.6 |
| EPS adjusted (₹) | 10.5 |
| 19% | |
| Annual report | Annual report for Mar 2026 |
| ₹ Cr | Mar 2026 |
|---|---|
| Equity capital | 112 |
| Reserves | 2,930 |
| Minority interest | 0 |
| 51 | |
| 336 | |
| Total equity & liabilities | 3,429 |
| 781 | |
| CWIP | 264 |
| Investments | 1,010 |
| 1,374 | |
| Total assets | 3,429 |
| ₹ Cr | Mar 2026 |
|---|---|
| 844 | |
| -702 | |
| -40 | |
| Net cash flow | 103 |
| Free cash flow | 633 |
| CFO / Operating profit % | 101.3% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 31 Mar 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities |
|---|---|---|---|---|
| CRDMO | 1,772.77 | 1,132.98 | 0 | 0 |
| Speciality Ingredients | 351.57 | 179.07 | 0 | 0 |
₹ crore by fiscal year